DE3683328D1 - Kontrastmittel fuer nmr-aufnahme. - Google Patents

Kontrastmittel fuer nmr-aufnahme.

Info

Publication number
DE3683328D1
DE3683328D1 DE8686305462T DE3683328T DE3683328D1 DE 3683328 D1 DE3683328 D1 DE 3683328D1 DE 8686305462 T DE8686305462 T DE 8686305462T DE 3683328 T DE3683328 T DE 3683328T DE 3683328 D1 DE3683328 D1 DE 3683328D1
Authority
DE
Germany
Prior art keywords
contrast agent
nmr recording
nmr
recording
contrast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686305462T
Other languages
English (en)
Inventor
Peter John Sadler
Charles Thomas Harding
James Duncan Kelly
Andrew Bruce Mcewen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet SA
Original Assignee
Guerbet SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet SA filed Critical Guerbet SA
Application granted granted Critical
Publication of DE3683328D1 publication Critical patent/DE3683328D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C07F11/005Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DE8686305462T 1985-07-19 1986-07-16 Kontrastmittel fuer nmr-aufnahme. Expired - Lifetime DE3683328D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858518300A GB8518300D0 (en) 1985-07-19 1985-07-19 Contrast agent

Publications (1)

Publication Number Publication Date
DE3683328D1 true DE3683328D1 (de) 1992-02-20

Family

ID=10582553

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686305462T Expired - Lifetime DE3683328D1 (de) 1985-07-19 1986-07-16 Kontrastmittel fuer nmr-aufnahme.

Country Status (5)

Country Link
US (1) US4880007A (de)
EP (1) EP0210043B1 (de)
JP (1) JP2516599B2 (de)
DE (1) DE3683328D1 (de)
GB (1) GB8518300D0 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US5066478A (en) * 1984-06-04 1991-11-19 The Dow Chemical Company Radio labeled organic amine phosphonic acid complexes for the treatment of calcific tumors
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
DE3684711D1 (de) * 1986-04-07 1992-05-07 Francois Dietlin In der tomo-densitometrie zu verwendende zusammensetzungen.
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5284646A (en) * 1986-07-03 1994-02-08 Advanced Magnetics Inc. Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
GB8701054D0 (en) * 1987-01-16 1987-02-18 Amersham Int Plc Contrast agent for nmr scanning
US4845165A (en) * 1987-03-13 1989-07-04 The Goodyear Tire & Rubber Company Anionic diene polymerization process with branching
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
US5130437A (en) * 1987-05-08 1992-07-14 Salutar, Inc. N,N'-bis-(pyridoxal)ethylenediamine-N,N'-diacetic acid derivatives
US4994259A (en) * 1987-05-08 1991-02-19 Salutar, Inc. Improvement in the method of NMR imaging employing a manganese II chelates of N,N'-bis[pyridoxal-alkylene (or cycloalkylene) (or arylene)]-N,N'-diacetic acid derivatives
WO1990001295A1 (en) 1988-08-04 1990-02-22 Advanced Magnetics, Incorporated Receptor mediated endocytosis type mri contrast agents
GB8900732D0 (en) * 1989-01-13 1989-03-08 Nycomed As Agents
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
US5320824A (en) * 1989-10-12 1994-06-14 Mallinckrodt Medical, Inc. Radionuclide labelled particles useful for radiation synovectomy
US5236695A (en) * 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
ATE140869T1 (de) * 1989-11-27 1996-08-15 Concat Ltd Qualitätssteigerung von mr-bildern von knochen und ähnlichem gewebe mittels paramagnetischer kationenkomplexe und polyphosphonatliganden
ATE129989T1 (de) 1990-10-04 1995-11-15 Britoil Plc Verfahren zur bekämpfung der kesselsteinbildung.
US5885549A (en) * 1991-02-01 1999-03-23 Imarx Pharmaceutical Corp. Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5240693A (en) * 1991-05-01 1993-08-31 University Of New Mexico Image enhancement by coadministration of biomodulators and structurally modified imaging agents
US5407659A (en) * 1991-10-22 1995-04-18 Mallinckrodt Medical, Inc. Treated calcium/oxyanion-containing particles for medical diagnostic imaging
WO1995027437A1 (en) * 1991-10-22 1995-10-19 Mallinckrodt Medical, Inc. Microfluidization of calcium/oxyanion-containing particles
US5342609A (en) * 1991-10-22 1994-08-30 Mallinckrodt Medical, Inc. Microfluidization of calcium/oxyanion-containing particles
US5344640A (en) * 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
US5342539A (en) * 1993-02-08 1994-08-30 Diatec Polymers Polyacrylamide-phosphonate flocculants and methods of making
US5409689A (en) * 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
DE4408729A1 (de) * 1994-03-15 1995-09-21 Hoechst Ag Nichtcyclische Chelatbildner auf Basis von Aminodialkylphosphoroxiden zur Herstellung von Technetium- oder Rheniumkomplexen
US5520904A (en) * 1995-01-27 1996-05-28 Mallinckrodt Medical, Inc. Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging
ATE309794T1 (de) 1995-06-26 2005-12-15 Chelator Llc Methode zur hemmung des wachstums von bakterien oder pilzen mit einem komplexbildner
CA2371728C (en) 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6278891B1 (en) 1999-08-25 2001-08-21 Echo Medical Systems, Llc Nuclear magnetic resonance method and apparatus for bone analysis and imaging
US6285901B1 (en) 1999-08-25 2001-09-04 Echo Medical Systems, L.L.C. Quantitative magnetic resonance method and apparatus for bone analysis
US6548042B2 (en) 2000-08-07 2003-04-15 Arstad Erik Bis-phosphonate compounds
US6776977B2 (en) 2001-01-09 2004-08-17 Bristol-Myers Squibb Pharma Company Polypodal chelants for metallopharmaceuticals
US20040038946A1 (en) * 2001-04-27 2004-02-26 Wilson Lon J. Fullerene-based drugs targeted to bone
AU2006335853B2 (en) 2006-01-20 2011-12-08 Nihon Medi-Physics Co., Ltd. Intermediate compound of technetium nitride complex for radiodiagnostic imaging
US20080038190A1 (en) * 2006-08-11 2008-02-14 Simpson Thomas J Composition apparatus and method for use in imaging
US8722020B2 (en) 2010-03-31 2014-05-13 General Electric Company Hydroxylated contrast enhancement agents
US8362281B2 (en) 2010-03-31 2013-01-29 General Electric Company Intermediates for hydroxylated contrast enhancement agents
US8765977B2 (en) 2010-03-31 2014-07-01 General Electric Company Hydroxylated contrast enhancement agents and imaging method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
US4749560A (en) * 1984-08-13 1988-06-07 Research Corporation Metal organo phosphorous compounds for NMR analysis
US4639364A (en) * 1984-11-14 1987-01-27 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging

Also Published As

Publication number Publication date
US4880007A (en) 1989-11-14
EP0210043A2 (de) 1987-01-28
EP0210043A3 (en) 1988-08-17
JPS6242934A (ja) 1987-02-24
JP2516599B2 (ja) 1996-07-24
GB8518300D0 (en) 1985-08-29
EP0210043B1 (de) 1992-01-08

Similar Documents

Publication Publication Date Title
DE3683328D1 (de) Kontrastmittel fuer nmr-aufnahme.
DE3672816D1 (de) Kontrastmittel fuer nmr-abbildung.
DE3679494D1 (de) Gleitstueckzusammenbau fuer magnetische koepfe.
DE3583782D1 (de) Einfuehrinstrument fuer katheter.
DE3680487D1 (de) Material fuer datenaufzeichnung.
DE3484037D1 (de) Aufzeichnungselement fuer eine information.
FI840232A (fi) Nmr-spoleanordning.
DE3586596D1 (de) Kassette fuer ein infusionssystem.
DE3671479D1 (de) Magnetische werkstoffe fuer magnetische kuehlung.
DE3776362D1 (de) Aufzeichnungsfluessigkeit.
DE3763262D1 (de) Kassette fuer kopien.
DE3676849D1 (de) Datenregistriereinrichtungen.
NO862598D0 (no) Festeanordning for sproeyte.
DE3684818D1 (de) Zwischendurchgangskonstruktion fuer fahrzeuge.
DE3784287D1 (de) Geraet fuer magnetische scheiben.
DE3678409D1 (de) Teststreifen.
DE3682217D1 (de) Aufzeichnungssystem.
DE3683826D1 (de) Geraet fuer eine verbesserte diagnostizierbarkeit.
DE3579217D1 (de) Aufzeichnungsfluessigkeit.
DE3777267D1 (de) Dispergiermittel fuer magnetische aufzeichnungstraeger.
DE3579417D1 (de) Reinigungssystem fuer magnetische aufzeichnungsplatten.
DE3672000D1 (de) Frontladevorrichtung fuer plattengeraet.
DE3670794D1 (de) Aufzeichnungsapparat.
DE3675518D1 (de) Blockierverhinderer fuer fahrzeuge.
DE3677566D1 (de) Fluoriertes pech.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee